US President Trump Sparks Panic Among Pregnant Women with False Autism Link Claim - Study Debunks Concerns
A high-profile study has put an end to the speculation surrounding paracetamol's alleged link to autism, ADHD, and intellectual disability. A comprehensive review of 43 studies, published in The Lancet Obstetrics, Gynaecology and Women's Health, found no evidence that taking paracetamol during pregnancy increases the risk of these conditions.
The study's lead author, Professor Asma Khalil, states that paracetamol remains a safe option for pregnant women when taken as guided. This news comes after US President Donald Trump sparked anxiety among expectant mothers by claiming that paracetamol causes autism. Trump's remarks were met with widespread condemnation from medical organizations and scientists worldwide.
The review of 43 studies analyzed data from over 1 million children, including 262,852 assessed for autism, 335,255 for ADHD, and 406,681 for intellectual disability. The study's findings confirm that there is no association between paracetamol exposure in utero and the development of these conditions.
Experts attribute the previous associations to familial and genetic factors, such as the tendency for autistic traits to run in families. Furthermore, underlying health conditions prompting regular paracetamol use during pregnancy may play a more significant role in shaping neurodevelopmental outcomes than the drug itself.
In response to Trump's claims, UK Health Secretary Wes Streeting advised women to ignore them, stating that the study's findings provide reassurance that paracetamol is safe to take when pregnant and in pain or suffering from fever. Other experts welcomed the study's results, emphasizing the importance of focusing on making society a better place for disabled individuals rather than pursuing false prevention measures.
The Lancet study serves as a significant validation of the safety of paracetamol during pregnancy, providing much-needed reassurance to expectant mothers worldwide.
A high-profile study has put an end to the speculation surrounding paracetamol's alleged link to autism, ADHD, and intellectual disability. A comprehensive review of 43 studies, published in The Lancet Obstetrics, Gynaecology and Women's Health, found no evidence that taking paracetamol during pregnancy increases the risk of these conditions.
The study's lead author, Professor Asma Khalil, states that paracetamol remains a safe option for pregnant women when taken as guided. This news comes after US President Donald Trump sparked anxiety among expectant mothers by claiming that paracetamol causes autism. Trump's remarks were met with widespread condemnation from medical organizations and scientists worldwide.
The review of 43 studies analyzed data from over 1 million children, including 262,852 assessed for autism, 335,255 for ADHD, and 406,681 for intellectual disability. The study's findings confirm that there is no association between paracetamol exposure in utero and the development of these conditions.
Experts attribute the previous associations to familial and genetic factors, such as the tendency for autistic traits to run in families. Furthermore, underlying health conditions prompting regular paracetamol use during pregnancy may play a more significant role in shaping neurodevelopmental outcomes than the drug itself.
In response to Trump's claims, UK Health Secretary Wes Streeting advised women to ignore them, stating that the study's findings provide reassurance that paracetamol is safe to take when pregnant and in pain or suffering from fever. Other experts welcomed the study's results, emphasizing the importance of focusing on making society a better place for disabled individuals rather than pursuing false prevention measures.
The Lancet study serves as a significant validation of the safety of paracetamol during pregnancy, providing much-needed reassurance to expectant mothers worldwide.